LSBio The Immunohistochemistry Antibody Company
  • Home
  • Products
    • All Antibodies
    • IHC-plus Antibodies
  • Services
    • Immunohistochemistry Studies
    • Tissue Cross-Reactivity Screening
  • Distributors
  • Resources
    • About our Tissue Bank
    • Customer Support
    • How to Buy
    • IHC-plus Protocol
    • LSBio Media
    • Publications
    • Antibody Reports
  • Company
    • About LifeSpan
    • Press Releases
    • Holiday Schedule
    • Contact Us
  • View Cart

Ovarian Cancer Screen 7 Tissue Microarray - LS-SOVCA7

This tissue microarray is available for use in LSBio Immunohistochemistry Studies only.

Catalog ID: LS-SOVCA7
Product Name: Ovarian Cancer Screen 7
Description: 36 various ovarian cancer with stage/grade and 12 normal/non-neoplastic ovarian specimens (duplicate cores)
Format: FFPE
Category: Human Tumor and Normal
QA/QC: H&E reviewed; IHC validated with a positive control antibody
Storage: Short term RT; Long term 4ºC
Clinical History: No
Tissue Marker: No
Stage/Grade: Yes
Core Diameter: 1.5 mm
Core Thickness: 4 µm
Cases: 48
Cores: 98
Slides Per Set: 1

LS-SOVCA7 Tissue Microarray Map

Slide Number 1
LABEL
 12345678910111213
AOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOva 
BOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOva 
COvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOva 
DOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOva 
EOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOva 
FOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOva 
GOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaUnk
HOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaOvaUnk
Diagnosis Type Legend
Benign non-neoplasticDiseasedInflammatoryMalignantMetastaticTumorUnknown
Element Tissue Legend
Ovary (Ova); Unknown (Unk);

LS-SOVCA7 Element Details

SlidePositionSpeciesGenderAgeTissueDiagnosisDiagnosis TypeTNM Tumor ClassificationTumor Stage
1A1HumanF29 yOvary (Ova)NormalBenign non-neoplastic  
1A2HumanF50 yOvary (Ova)NormalBenign non-neoplastic  
1A3HumanF51 yOvary (Ova)Cystadenocarcinoma, SerousMalignantT2N0M0II-III
1A4HumanF47 yOvary (Ova)Mucinous cystadenomaTumor  
1A5HumanF35 yOvary (Ova)ThecomaTumor  
1A6HumanF68 yOvary (Ova)Mucinous cystadenomaTumor  
1A7HumanF57 yOvary (Ova)Mucinous cystadenomaTumor  
1A8HumanF67 yOvary (Ova)ThecomaTumor  
1A9HumanF47 yOvary (Ova)ThecomaTumor  
1A10HumanF55 yOvary (Ova)ThecomaTumor  
1A11HumanF43 yOvary (Ova)Granulosa cell tumorTumor  
1A12HumanF52 yOvary (Ova)Granulosa cell tumorTumor  
1B1HumanF29 yOvary (Ova)NormalBenign non-neoplastic  
1B2HumanF50 yOvary (Ova)NormalBenign non-neoplastic  
1B3HumanF51 yOvary (Ova)Cystadenocarcinoma, SerousMalignantT2N0M0II-III
1B4HumanF47 yOvary (Ova)Mucinous cystadenomaTumor  
1B5HumanF35 yOvary (Ova)ThecomaTumor  
1B6HumanF68 yOvary (Ova)Mucinous cystadenomaTumor  
1B7HumanF57 yOvary (Ova)Mucinous cystadenomaTumor  
1B8HumanF67 yOvary (Ova)ThecomaTumor  
1B9HumanF47 yOvary (Ova)ThecomaTumor  
1B10HumanF55 yOvary (Ova)ThecomaTumor  
1B11HumanF43 yOvary (Ova)Granulosa cell tumorTumor  
1B12HumanF52 yOvary (Ova)Granulosa cell tumorTumor  
1C1HumanF33 yOvary (Ova)Cystadenocarcinoma, SerousMalignantT1N0M0I-II
1C2HumanF34 yOvary (Ova)Cystadenocarcinoma, SerousMalignantT2N0M0II
1C3HumanF56 yOvary (Ova)Cystadenocarcinoma, SerousMalignantT1N0M0II
1C4HumanF45 yOvary (Ova)Cystadenocarcinoma, SerousMalignantT1N0M0II
1C5HumanF43 yOvary (Ova)Cystadenocarcinoma, SerousMalignantT1N0M0III
1C6HumanF51 yOvary (Ova)Cystadenocarcinoma, SerousMalignantT3N1M0III
1C7HumanF54 yOvary (Ova)Cystadenocarcinoma, SerousMalignantT2N0M0II
1C8HumanF53 yOvary (Ova)Cystadenocarcinoma, SerousMalignantT1N0M0II-III
1C9HumanF22 yOvary (Ova)Mucinous cystadenoma, BoderlineTumor  
1C10HumanF20 yOvary (Ova)Cystadenocarcinoma, MucinousMalignantT2N0M0
1C11HumanF47 yOvary (Ova)Cystadenocarcinoma, MucinousMalignantT1N0M0
1C12HumanF43 yOvary (Ova)Cystadenocarcinoma, MucinousMalignantT2N0M0III
1D1HumanF33 yOvary (Ova)Cystadenocarcinoma, SerousMalignantT1N0M0I-II
1D2HumanF34 yOvary (Ova)Cystadenocarcinoma, SerousMalignantT2N0M0II
1D3HumanF56 yOvary (Ova)Cystadenocarcinoma, SerousMalignantT1N0M0II
1D4HumanF45 yOvary (Ova)Cystadenocarcinoma, SerousMalignantT1N0M0II
1D5HumanF43 yOvary (Ova)Cystadenocarcinoma, SerousMalignantT1N0M0III
1D6HumanF51 yOvary (Ova)Cystadenocarcinoma, SerousMalignantT3N1M0III
1D7HumanF54 yOvary (Ova)Cystadenocarcinoma, SerousMalignantT2N0M0II
1D8HumanF53 yOvary (Ova)Cystadenocarcinoma, SerousMalignantT1N0M0II-III
1D9HumanF22 yOvary (Ova)Mucinous cystadenoma, BoderlineTumor  
1D10HumanF20 yOvary (Ova)Cystadenocarcinoma, MucinousMalignantT2N0M0
1D11HumanF47 yOvary (Ova)Cystadenocarcinoma, MucinousMalignantT1N0M0
1D12HumanF43 yOvary (Ova)Cystadenocarcinoma, MucinousMalignantT2N0M0III
1E1HumanF18 yOvary (Ova)Cystadenocarcinoma, MucinousMalignantT1N0M0I
1E2HumanF25 yOvary (Ova)Cystadenocarcinoma, MucinousMalignantT1N0M0I-II
1E3HumanF24 yOvary (Ova)Cystadenocarcinoma, MucinousMalignantT1N0M0I
1E4HumanF51 yOvary (Ova)Endometrioid adenocarcinomaMalignantT1N0M0I
1E5HumanF50 yOvary (Ova)Endometrioid adenocarcinomaMalignantT1N0M0I-II
1E6HumanF17 yOvary (Ova)Endometrioid adenocarcinomaMalignantT1N0M0I
1E7HumanF42 yOvary (Ova)Endometrioid adenocarcinomaMalignantT1N0M0I
1E8HumanF25 yOvary (Ova)Endometrioid adenocarcinomaMalignantT2N0M0I-II
1E9HumanF42 yOvary (Ova)Endometrioid adenocarcinomaMalignantT1N0M0II
1E10HumanF42 yOvary (Ova)Endometrioid adenocarcinomaMalignantT1N0M0II
1E11HumanF42 yOvary (Ova)Endometrioid adenocarcinomaMalignantT1N0M0II
1E12HumanF63 yOvary (Ova)Endometrioid adenocarcinomaMalignantT1N0M0III
1F1HumanF18 yOvary (Ova)Cystadenocarcinoma, MucinousMalignantT1N0M0I
1F2HumanF25 yOvary (Ova)Cystadenocarcinoma, MucinousMalignantT1N0M0I-II
1F3HumanF24 yOvary (Ova)Cystadenocarcinoma, MucinousMalignantT1N0M0I
1F4HumanF51 yOvary (Ova)Endometrioid adenocarcinomaMalignantT1N0M0I
1F5HumanF50 yOvary (Ova)Endometrioid adenocarcinomaMalignantT1N0M0I-II
1F6HumanF17 yOvary (Ova)Endometrioid adenocarcinomaMalignantT1N0M0I
1F7HumanF42 yOvary (Ova)Endometrioid adenocarcinomaMalignantT1N0M0I
1F8HumanF25 yOvary (Ova)Endometrioid adenocarcinomaMalignantT2N0M0I-II
1F9HumanF42 yOvary (Ova)Endometrioid adenocarcinomaMalignantT1N0M0II
1F10HumanF42 yOvary (Ova)Endometrioid adenocarcinomaMalignantT1N0M0II
1F11HumanF42 yOvary (Ova)Endometrioid adenocarcinomaMalignantT1N0M0II
1F12HumanF63 yOvary (Ova)Endometrioid adenocarcinomaMalignantT1N0M0III
1G1HumanF48 yOvary (Ova)Endometrioid adenocarcinomaMalignantT1N0M0III
1G2HumanF68 yOvary (Ova)Endometrioid adenocarcinomaMalignantT1N0M0III
1G3HumanF52 yOvary (Ova)Endometrioid adenocarcinomaMalignantT2N0M0III
1G4HumanF58 yOvary (Ova)Endometrioid adenocarcinomaMalignantT2N0M0III
1G5HumanF48 yOvary (Ova)Undifferentiated carcinomaMalignantT2N0M0III
1G6HumanF57 yOvary (Ova)Undifferentiated carcinomaMalignantT2N0M0III
1G7HumanF54 yOvary (Ova)Undifferentiated carcinomaMalignantT2N0M0III
1G8HumanF17 yOvary (Ova)DysgerminomaMalignantT2N0M0
1G9HumanF40 yOvary (Ova)Endodermal sinus tumorTumorT1N0M0
1G10HumanF34 yOvary (Ova)Endodermal sinus tumorTumorT1N0M0
1G11HumanF36 yOvary (Ova)Stromal sarcomaMalignantT1N0M0
1G12HumanF31 yOvary (Ova)TeratomaTumor  
1G13UnknownU Unknown (Unk)UnknownUnknown  
1H1HumanF48 yOvary (Ova)Endometrioid adenocarcinomaMalignantT1N0M0III
1H2HumanF68 yOvary (Ova)Endometrioid adenocarcinomaMalignantT1N0M0III
1H3HumanF52 yOvary (Ova)Endometrioid adenocarcinomaMalignantT2N0M0III
1H4HumanF58 yOvary (Ova)Endometrioid adenocarcinomaMalignantT2N0M0III
1H5HumanF48 yOvary (Ova)Undifferentiated carcinomaMalignantT2N0M0III
1H6HumanF57 yOvary (Ova)Undifferentiated carcinomaMalignantT2N0M0III
1H7HumanF54 yOvary (Ova)Undifferentiated carcinomaMalignantT2N0M0III
1H8HumanF17 yOvary (Ova)DysgerminomaMalignantT2N0M0
1H9HumanF40 yOvary (Ova)Endodermal sinus tumorTumorT1N0M0
1H10HumanF34 yOvary (Ova)Endodermal sinus tumorTumorT1N0M0
1H11HumanF36 yOvary (Ova)Stromal sarcomaMalignantT1N0M0
1H12HumanF31 yOvary (Ova)TeratomaTumor  
1H13UnknownU Unknown (Unk)UnknownUnknown  
PLEASE NOTE

For RESEARCH USE ONLY. Not intended for human diagnostic or therapeutic purposes.

Not for resale without prior written consent from LifeSpan BioSciences, Inc.

Copyright © 2013 LifeSpan BioSciences, Inc. All Rights Reserved